GeneTex knockout/knockdown validated antibodies
21 July, 2017GeneTex is conducting knockdown-based validation as a fundamental component of its antibody quality assurance process. To date, the compnany has evaluated over 500 products covering research topics such as apoptosis, metabolism, epithelial–mesenchymal transition and neurodegenerative diseases.
GeneTex Cancer Immune Checkpoint Antibodies
29 May, 2017GeneTex has over 60 Cancer Immune Checkpoint Antibodies to choose from, including key targets such as CTLA4, FOXP3, LAG3, OX40L and PD-L1, with validations across various applications.
Antibodies found to control seizures in epileptic mice
24 May, 2017Japanese researchers have reported the effect of a particular type of monoclonal antibody on epilepsy in mice, with promising results.
GeneTex dengue virus antibodies
15 March, 2017GeneTex offers a comprehensive catalogue of antibodies to dengue virus (DENV) structural and non-structural viral proteins.
Innova Biosciences LATEX Bead Conjugation Kits
16 January, 2017Innova Biosciences has introduced a range of LATEX Bead Conjugation Kits. The simple-to-use, one-step kits are suitable for covalently conjugating antibodies, proteins and peptides (or any other biomolecule with an amine group) to specially treated latex beads without the need for extensive optimisation.
Cosmo Bio Histone H3 and modified Histone H3 antibodies
11 August, 2016The versatile set of anti-histone monoclonal antibodies offered by Cosmo Bio is a valuable addition to any lab's epigenetic toolbox.
Zika virus antibody now available for research
13 May, 2016Vanderbilt University has developed a Zika polyclonal antibody that recognises the human Zika envelope (E) protein and can be utilised for a range of applications to study the virus and its function.
MédiMabs MAP/RAP Amplification Kit
22 December, 2015MédiMabs offers a rabbit antibody that acts as an immunohistochemical alternative to existing staining systems, suitable for use with mouse (MAP) or rat (RAP) primary antibodies.
Abcam knockout-validated antibodies
17 December, 2015With the increasing need for highly specific antibodies, Abcam introduces KO validation as a standard quality control protocol for antibodies at scale.
QIMR Berghofer and Bristol-Myers Squibb collaborate on cancer antibodies
31 August, 2015QIMR Berghofer Medical Research Institute and Bristol-Myers Squibb have signed a research collaboration and licence agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology target.
Call for standardisation of antibodies used in research
06 February, 2015An opinion piece in the journal Nature, representing over 100 antibody experts around the world, has called for a standardised approach to the creation and use of antibodies in research and therapeutics.
Solvanix to improve antibody stability
16 January, 2015Biotech start-up Solvanix was launched this week with funding from the Medical Research Commercialisation Fund (MRCF). The aim of the company is to commercialise a technology for improving stability and reducing the aggregation (stickiness) of fully human antibodies - a side effect of their purification, concentration and storage for use as therapeutic drugs.
Enzo Life Sciences Diglycyl Lysine, mAb (GX41), monoclonal for ubiquitin remnant profiling
15 January, 2015The Enzo Life Sciences Diglycyl Lysine, mAb (GX41), is a highly specific monoclonal for ubiquitin remnant profiling that recognises the diglycyl-lysine residue left behind after the ubiquitin itself is long gone - with no detectable reactivity to non-modified lysines.
Dako and Cell Signaling Technology partner in companion diagnostics
13 January, 2015Antibody provider Cell Signaling Technology (CST) has entered into a strategic partnership to supply antibodies for use in Dako companion diagnostics products.
